These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 8878600)
1. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. Bethell DB; Day NP; Dung NM; McMullin C; Loan HT; Tam DT; Minh LT; Linh NT; Dung NQ; Vinh H; MacGowan AP; White LO; White NJ Antimicrob Agents Chemother; 1996 Sep; 40(9):2167-72. PubMed ID: 8878600 [TBL] [Abstract][Full Text] [Related]
2. Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children. Vinh H; Duong NM; Phuong le T; Truong NT; Bay PV; Wain J; Diep TS; Ho VA; White NJ; Day NP; Parry CM Ann Trop Paediatr; 2005 Mar; 25(1):17-22. PubMed ID: 15814044 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057 [TBL] [Abstract][Full Text] [Related]
4. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers. Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. Cao XT; Kneen R; Nguyen TA; Truong DL; White NJ; Parry CM Pediatr Infect Dis J; 1999 Mar; 18(3):245-8. PubMed ID: 10093945 [TBL] [Abstract][Full Text] [Related]
8. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Vinh H; Wain J; Vo TN; Cao NN; Mai TC; Bethell D; Nguyen TT; Tu SD; Nguyen MD; White NJ Antimicrob Agents Chemother; 1996 Apr; 40(4):958-61. PubMed ID: 8849259 [TBL] [Abstract][Full Text] [Related]
9. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Parry CM; Ho VA; Phuong le T; Bay PV; Lanh MN; Tung le T; Tham NT; Wain J; Hien TT; Farrar JJ Antimicrob Agents Chemother; 2007 Mar; 51(3):819-25. PubMed ID: 17145784 [TBL] [Abstract][Full Text] [Related]
10. The clinical pharmacokinetics of levofloxacin. Fish DN; Chow AT Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit. Rebuck JA; Fish DN; Abraham E Pharmacotherapy; 2002 Oct; 22(10):1216-25. PubMed ID: 12389872 [TBL] [Abstract][Full Text] [Related]
12. Dose related pharmacokinetics of ofloxacin in healthy volunteers. Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149 [TBL] [Abstract][Full Text] [Related]
13. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Tran TH; Bethell DB; Nguyen TT; Wain J; To SD; Le TP; Bui MC; Nguyen MD; Pham TT; Walsh AL Clin Infect Dis; 1995 Apr; 20(4):917-23. PubMed ID: 7795095 [TBL] [Abstract][Full Text] [Related]
14. Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects. Lee LJ; Hafkin B; Lee ID; Hoh J; Dix R Antimicrob Agents Chemother; 1997 Oct; 41(10):2196-200. PubMed ID: 9333047 [TBL] [Abstract][Full Text] [Related]
15. Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers. Yuk JH; Nightingale CH; Quintiliani R; Sweeney KR Antimicrob Agents Chemother; 1991 Feb; 35(2):384-6. PubMed ID: 2024973 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin. Nau R; Kinzig M; Dreyhaupt T; Kolenda H; Sörgel F; Prange HW Antimicrob Agents Chemother; 1994 Aug; 38(8):1849-53. PubMed ID: 7986019 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects. Farinotti R; Trouvin JH; Bocquet V; Vermerie N; Carbon C Antimicrob Agents Chemother; 1988 Oct; 32(10):1590-2. PubMed ID: 3190187 [TBL] [Abstract][Full Text] [Related]